1.68
0.00%
+0.00
China SXT Pharmaceuticals Inc stock is currently priced at $1.68, with a 24-hour trading volume of 60,713.
It has seen a +0.00% increased in the last 24 hours and a -10.16% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.69 pivot point. If it approaches the $1.63 support level, significant changes may occur.
China SXT Pharmaceuticals Inc Stock (SXTC) Financials Data
China SXT Pharmaceuticals Inc (SXTC) Revenue 2023
SXTC reported a revenue (TTM) of $1.97 million for the quarter ending March 31, 2023, a -58.73% decline year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Net Income 2023
SXTC net income (TTM) was -$5.93 million for the quarter ending March 31, 2023, a -115.95% decrease year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Cash Flow 2023
SXTC recorded a free cash flow (TTM) of -$151.40 thousand for the quarter ending March 31, 2023, a +89.26% increase year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Earnings per Share 2023
SXTC earnings per share (TTM) was -$24.31 for the quarter ending March 31, 2023, a +74.54% growth year-over-year.
China SXT Pharmaceuticals Inc Stock (SXTC) Latest News
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Down 100 Points; US Manufacturing PMI Falls In December
Benzinga
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
US Stocks Edge Higher On Last Trading Day Of 2023; Chicago PMI Falls In December
Benzinga
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
GlobeNewswire Inc.
About China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Cap:
|
Volume (24h):